PMC full text:
Published online 2010 May 25. doi: 10.1371/journal.pone.0010817
Table 1
Natural killer cell cytotoxicity and dipeptidyl peptidase IV/CD26 in chronic fatigue syndrome casesa compared to controlsb.
| Variable | Number of CFS Cases | Median (25–75th percentile) | Number of Healthy Controls | Median (25–75th percentile) | p |
| NKCC% | 176 | 12 (8–21) | 230 | 28 (20–37) | .000 |
| % CD26+CD2+ Cells | 75 | 61 (55–66) | 100 | 52 (47–59) | .000 |
| sCD26 in Serum (ng/ml) | 73 | 489 (396–643) | 122 | 671 (496–871) | .000 |
| rMol CD26/CD2+ Cell | 77 | 3625 (2844–4633) | 102 | 4388 (3600–5388) | .001 |
a>80% female, average age 48;
b>80% female, average age 47.